The results of the investigation are inconclusive since the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed.Based on the information received, the cause of the reported pericardial effusion could not be conclusively determined.Per the ifu, cardiac perforation is a known risk during the use of this device.
|
Related manufacturer reference: 3005334138-2020-00310, 3008452825-2020-00356, 2030404-2020-00052.Following a typical flutter ablation, a pericardial effusion occurred.As patient was being woken up from anesthesia, the patient became hypotensive and rhythm went from sinus to afib during pacing.An ultrasound confirmed a pericardial effusion.Phenylephrine, vitamin k and 2 units of ffp were administered.It was indicated the cause may have been the movement of the duodeca catheter and ablation of the cavo-tricuspid isthmus , however the cause and location of the effusion remains unknown.No further intervention was needed and the patient was stabilized.There were no performance issues with any abbott device.
|